Alnylam Pharmaceuticals reported $153.82M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amgen AMGN:US $ 1.38B 130M
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Arrowhead Research ARWR:US $ 17.86M 1.67M
Avrobio Inc AVRO:US 8.83M 474K
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Moderna Inc MRNA:US 121M 44M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NVS:US 3.71B 190M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Regulus Therapeutics RGLS:US $ 2.49M 10K
Sangamo Biosciences SGMO:US $ 16.49M 338K
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Takeda 4502:JP 219.84B 14.55B
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Xencor XNCR:US $ 8.86M 637K
YTE INCY:US $ 168.86M 15.06M